Orthofix Medical Inc. announced a realignment of its Spine leadership team and released preliminary Q1 2026 results, marking the first major corporate action since its 2023 merger with SeaSpine.
The realignment consolidates decision‑making by expanding the role of Shaeffer Bannigan to Leader, Spinal Solutions, and streamlines reporting within the spine business unit. Management said the changes “clarify leadership alignment and ownership across our Spine portfolio while strengthening coordination across our commercial, strategic, and enabling technology teams.”
Orthofix reported preliminary unaudited net sales of $196.7 million for the quarter ended March 31, 2026, and a pro‑forma net sales figure of $196.4 million. These figures represent a 0.4 % reported growth and a 3 % constant‑currency pro‑forma increase versus Q1 2025, when net sales were $193.6 million and pro‑forma sales were $189.2 million.
The modest growth was driven by distributor transitions and the integration of SeaSpine’s product lines, while the company’s upcoming launch of the VIRATA fixation system is positioned to add momentum later in the year. Management noted that “our preliminary first quarter net sales reflect meaningful progress through recent distributor transitions as we gear up for new product launches later this year.” The discontinuation of the M6 product line remains a headwind that the company is managing as it refocuses its portfolio.
Orthofix reaffirmed its 2026 guidance, projecting net sales of $850 million to $860 million and non‑GAAP adjusted EBITDA of $95 million to $98 million. The company expects a 70‑basis‑point margin expansion in 2026 versus 2025, underscoring confidence in its execution strategy. “Precise execution, faster decision‑making and innovation is the focus for Orthofix in 2026,” the CEO added, highlighting the company’s commitment to shareholder value.
The leadership realignment, combined with steady Q1 results and a reaffirmed guidance outlook, positions Orthofix to accelerate growth, maintain margin expansion, and successfully launch new spine solutions such as the VIRATA fixation system.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.